CADENCE CAPITAL MANAGEMENT LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 118 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
CADENCE CAPITAL MANAGEMENT LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,548,000
+25.2%
335,090
+4.3%
0.22%
+7.7%
Q1 2020$1,236,000
-2.4%
321,128
-4.9%
0.21%
+53.7%
Q4 2019$1,266,000
-35.7%
337,721
-9.0%
0.14%
-51.4%
Q3 2019$1,970,000371,0750.28%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders